Peripheral Neuropathy News and Research

RSS
Peripheral neuropathy describes damage to the peripheral nervous system, which transmits information from the brain and spinal cord to every other part of the body.

More than 100 types of peripheral neuropathy have been identified, each with its own characteristic set of symptoms, pattern of development, and prognosis. Impaired function and symptoms depend on the type of nerves -- motor, sensory, or autonomic -- that are damaged. Some people may experience temporary numbness, tingling, and pricking sensations, sensitivity to touch, or muscle weakness. Others may suffer more extreme symptoms, including burning pain (especially at night), muscle wasting, paralysis, or organ or gland dysfunction. Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, and vascular and metabolic disorders. Acquired peripheral neuropathies are caused by systemic disease, trauma from external agents, or infections or autoimmune disorders affecting nerve tissue. Inherited forms of peripheral neuropathy are caused by inborn mistakes in the genetic code or by new genetic mutations.
USF awarded $2.2 million to study neuromuscular effects of chemotherapy in breast cancer survivors

USF awarded $2.2 million to study neuromuscular effects of chemotherapy in breast cancer survivors

Raising Awareness of Coeliac Disease with Coeliac UK

Raising Awareness of Coeliac Disease with Coeliac UK

LMRI scientists discover cause of debilitating eye disease

LMRI scientists discover cause of debilitating eye disease

First genetic cause for a rare eye disease discovered

First genetic cause for a rare eye disease discovered

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

FDA grants approval for generic versions of Lyrica

FDA grants approval for generic versions of Lyrica

Study shows potential culprit behind Lupus

Study shows potential culprit behind Lupus

Researchers identify genetic factor linked to development of diabetic peripheral neuropathy

Researchers identify genetic factor linked to development of diabetic peripheral neuropathy

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

University of Virginia chemist identifies potential addiction-free pain reliever

University of Virginia chemist identifies potential addiction-free pain reliever

Processed aconite root could relieve neuropathic pain in murine peripheral neuropathy

Processed aconite root could relieve neuropathic pain in murine peripheral neuropathy

IUPUI researcher receives $2.85 million grant to find ways to improve bone strength

IUPUI researcher receives $2.85 million grant to find ways to improve bone strength

Scientists develop new gene therapy that prevents axon destruction in mice

Scientists develop new gene therapy that prevents axon destruction in mice

Statins associated with low risk of side effects

Statins associated with low risk of side effects

New first-line treatment for peripheral T-cell lymphoma approved by FDA

New first-line treatment for peripheral T-cell lymphoma approved by FDA

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Study finds differences in side-effects experienced by male and female OG cancer patients

Study finds differences in side-effects experienced by male and female OG cancer patients

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Common painkiller not effective in controlling chronic pain after traumatic nerve injury

Common painkiller not effective in controlling chronic pain after traumatic nerve injury

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma